Financial News
Articles published by NeuroPace, Inc.
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting
December 01, 2023
From NeuroPace, Inc.
Via GlobeNewswire
Tickers
NPCE
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
November 06, 2023
From NeuroPace, Inc.
Via GlobeNewswire
Tickers
NPCE
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
NeuroPace to Participate in Upcoming Investor Conferences
August 24, 2023
From NeuroPace, Inc.
Via GlobeNewswire
Tickers
NPCE
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
August 08, 2023
From NeuroPace, Inc.
Via GlobeNewswire
Tickers
NPCE
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
NeuroPace Announces Inducement Grants Under Listing Rule 5635(c)(4) of The Nasdaq Stock Market
July 19, 2023
From NeuroPace, Inc.
Via GlobeNewswire
Tickers
NPCE
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
NeuroPace Announces CEO Transition
June 28, 2023
From NeuroPace, Inc.
Via GlobeNewswire
Tickers
NPCE
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
May 04, 2023
From NeuroPace, Inc.
Via GlobeNewswire
Tickers
NPCE
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
February 10, 2023
From NeuroPace, Inc.
Via GlobeNewswire
Tickers
NPCE
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://mms.businesswire.com/media/20221130005182/en/732331/5/NeuroPace-Logo-Horiz-rgb-med.jpg)
NeuroPace Feasibility Study of Its RNS System for Lennox-Gastaut Syndrome Now Underway
November 30, 2022
From NeuroPace, Inc.
Via Business Wire
Tickers
NPCE
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
NeuroPace Reports Third Quarter 2022 Financial Results and Provides a Business Update
November 08, 2022
From NeuroPace, Inc.
Via GlobeNewswire
Tickers
NPCE
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://mms.businesswire.com/media/20221011005448/en/720850/5/NeuroPace-Logo-Horiz-rgb-med_%281%29.jpg)
![](https://mms.businesswire.com/media/20220504005333/en/720850/5/NeuroPace-Logo-Horiz-rgb-med_%281%29.jpg)
NeuroPace Announces First Patient Treated in Pivotal Study Evaluating the RNS System in Adolescents
May 04, 2022
From NeuroPace, Inc.
Via Business Wire
Tickers
NPCE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.